Moving the Goalpost Toward Remission: The Case for Combination Immunomodulatory Therapies in Psoriatic Arthritis

被引：6
作者：
Scher, Jose U. [1 ,2 ]
Ogdie, Alexis [3 ]
Merola, Joseph F. [4 ,5 ]
Ritchlin, Christopher [6 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] NYU, Langone Orthoped Hosp, New York, NY USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ Rochester, Sch Med & Dent, Rochester, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷 / 09期
关键词：
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; PHASE-3; SAFETY; CHEMOTHERAPY; ETANERCEPT; EFFICACY;
D O I：
10.1002/art.41765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1574 / 1578
页数：5
相关论文
共 32 条
  • [1] Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO
  • [2] 2-M
  • [3] Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: A systematic review and meta-analysis
    Boleto, Goncalo
    Kanagaratnam, Lukshe
    Drame, Moustapha
    Salmon, Jean-Hugues
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (01) : 35 - 42
  • [4] Identification of myeloid cells in the human enthesis as the main source of local IL-23 production
    Bridgewood, Charlie
    Watad, Abdulla
    Russell, Tobias
    Palmer, Timothy M.
    Marzo-Ortega, Helena
    Khan, Almas
    Millner, Peter A.
    Dunsmuir, Robert
    Rao, Abhay
    Loughenbury, Peter
    Wittmann, Miriam
    Cuthbert, Richard J.
    McGonagle, Dennis G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (07) : 929 - 933
  • [5] Timeline - Chemotherapy and the war on cancer
    Chabner, BA
    Roberts, TG
    [J]. NATURE REVIEWS CANCER, 2005, 5 (01) : 65 - 72
  • [6] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    FURST, D
    GOLDSMITH, C
    KATZ, LM
    LIGHTFOOT, R
    PAULUS, H
    STRAND, V
    TUGWELL, P
    WEINBLATT, M
    WILLIAMS, HJ
    WOLFE, F
    KIESZAK, S
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : 727 - 735
  • [7] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID
    FREDRIKSSON, T
    PETTERSSON, U
    [J]. DERMATOLOGICA, 1978, 157 (04): : 238 - 244
  • [8] EFFECTIVENESS OF COMBINATIONS OF ANTILEUKEMIC AGENTS IN INDUCING AND MAINTAINING REMISSION IN CHILDREN WITH ACUTE LEUKEMIA
    FREI, E
    KARON, M
    LEVIN, RH
    FREIREICH, EJ
    TAYLOR, RJ
    HANANIAN, J
    SELAWRY, O
    HOLLAND, JF
    HOOGSTRATEN, B
    WOLMAN, IJ
    ABIR, E
    SAWITSKY, A
    LEE, S
    MILLS, SD
    BURGERT, EO
    SPURR, CL
    PATTERSON, RB
    EBAUGH, FG
    JAMES, GW
    MOON, JH
    [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1965, 26 (05): : 642 - +
  • [9] Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis
    Genovese, Mark C.
    Weinblatt, Michael E.
    Mease, Philip J.
    Aelion, Jacob A.
    Peloso, Paul M.
    Chen, Kun
    Li, Yihan
    Liu, John
    Othman, Ahmed A.
    Khatri, Amit
    Mansikka, Heikki T.
    Leszczynski, Piotr
    [J]. RHEUMATOLOGY, 2018, 57 (11) : 1972 - 1981
  • [10] Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
    Genovese, MC
    Cohen, S
    Moreland, L
    Lium, D
    Robbins, S
    Newmark, R
    Bekker, P
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (05): : 1412 - 1419
1234